KS

Kajalben Shyamalbhai Patel

Active Director Director DIN 11103659
DIN 11103659 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kajalben Shyamalbhai Patel

Data last updated:

Kajalben Shyamalbhai Patel is a Director at Resiidier Healthcare Private Limited (since 2025).

DIN 11103659
Primary Designation Director
First Appointment 13 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Resiidier Healthcare Private Limited U86100GJ2025PTC162857
Director13 May 20252025Active

Board colleagues of Kajalben Shyamalbhai Patel

Directorship timeline

Open interactive timeline →
Resiidier Healthcare Private Limited
Premium access

Shareholding and investment profile for Kajalben Shyamalbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kajalben Shyamalbhai Patel

Kajalben Shyamalbhai Patel currently holds 1 directorship: Resiidier Healthcare Private Limited (Director, since 13 May 2025).

Kajalben Shyamalbhai Patel was first appointed on 13 May 2025 as Director at Resiidier Healthcare Private Limited.

The current boards of Kajalben Shyamalbhai Patel's companies include Akshay Indravadan Joshi (Resiidier Healthcare Private Limited), Sagar Rajendrabhai Jani (Resiidier Healthcare Private Limited), Shraddha Sagarbhai Jani (Resiidier Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available